BioSciPons works from any starting point for a customised service:
an idea, a dataset, a book chapter, a scientific report, or the simple need to put a safe device into the market.
You tell us what you need, we do the thinking!
I’m Biochemist and worked in biomedical research for the past 15 years.
I work with a wide network of scientists from different fields (neuroscience, oncology, drug discovery, geneticists, dermatologists, etc...) to assure the most accurate writing. My own expertise lies in cardiology, neurology and oncology, all the research fields I worked throughout the years.
I have extensive experience in clinical research, scientific writing and biostatistics. The results of my research work as a Marie-Curie Early Stage Researcher in the Cardiovascular Center of the Charité (Berlin, Germany) led to a clinical trial for the treatment of patients with ischemic heart disease. I was award a Grant from the Boehringer Ingelheim Funds, which allowed me to spend several periods in the USA.
Innovation and creativity help me solve technical problems efficiently. When I was a researcher at the Yale Cardiovascular Research Center, I developed new techniques in order to optimize our group results. I served as a liaison from my laboratory to several collaborating labs in Yale and in other institutions. My most recent publication from this group was just approved for publishing in January 2019. Part of the work that I did in 2010 was still innovative after 9 years to be published in one of the most prominent journals of the field.
I understand the importance of writing and wording, not only in written form to peers but also to deliver valuable information to the consumer. As an example, I was honored to receive the Vienna and the European Science Slam award, and was nominated Young Science Journalist of the Year (2021) by the Association of British Science Writers (ABSW). My presentation entitled "Creativity in Regulatory Affairs: lessons learned from the COVID-19 pandemic" was accepted to the Regulatory Affairs Professional Society (RAPS) 2022-EuroConvergence meeting.
My way of communicating science to a lay audience, testifies my creativity, enthusiasm and ability to communicate science effectively. I am able to distill complex scientific ideas for a broad audience in a way that is both informative and entertaining.Clinical Evaluation Reports, Medical Systematic Literature Reviews, FDA and EU MDR & IVDR are a staple at my desk. There is nothing clearer than reading medical regulation!